We revisit the computation of the phase space factors (PSF) involved in the positron decay and electron capture (EC) processes for a large number of nuclei of experimental interest. To obtain the electron/positron wave functions needed in computation, we develop a code for solving accurately the Dirac equation with a nuclear potential derived from a realistic proton density distribution in the nucleus. The finite nuclear size (FNS) and screening effects are included through recipes which differ from those used in previous calculations. Comparing our results with former calculations employing approximate methods but computed with the same Q-values, we find a close agreement for positron decays, while for the EC process there are relevant differences. For the EC process we also find that the screening effect has a notable influence on the computed PSF values specially for light nuclei. Further, we re-computed the same PSF values but using the most recent Q-values reported in literature. In several cases these new Q-values differ significantly from the older ones, which results in large differences in the PSF values as compared with previous results. These new PSF values proposed here, can contribute to a more reliable calculation of the beta decay rates, which are key quantities in the study of nuclei far from the stability line, as well as to better understanding of the stellar evolution.
Observable effects for the Lorentz invariance violation (LIV) at a low energy scale can also be investigated in double beta decay (DBD). For example, by comparing the theoretical predictions with a precise analysis of the summed energy spectra of electrons in 2νββ decay, one can constrain theå
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.